Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11701326 Amlodipine formulations

Patent 11701326 was granted and assigned to Azurity Pharmaceuticals on July, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Azurity Pharmaceuticals
Azurity Pharmaceuticals
0
Date Filed
August 22, 2022
0
Date of Patent
July 18, 2023
0
Patent Applicant
Azurity Pharmaceuticals
Azurity Pharmaceuticals
0
Patent Application Number
17892738
0
Patent Citations
‌
US Patent 10695329 Amlodipine formulations
0
‌
US Patent 10799453 Amlodipine formulations
0
‌
US Patent 10952998 Amlodipine formulations
0
‌
US Patent 10894039 Amlodipine formulations
0
‌
US Patent 7115638 Amide derivative of amlodipine
0
‌
US Patent 7199247 Amide derivative of amlodipine
0
‌
US Patent 7772400 Optical resolution method of amlodipine
0
‌
US Patent 8158146 Stable combinations of amlodipine besylate and benazepril hydrochloride
0
‌
US Patent 8377994 Use of roll compacted pyrogenically produced silicon dioxide in pharmaceutical compositions
0
Patent Citations Received
‌
US Patent 11918685 Amlodipine formulations
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11701326
0
Patent Primary Examiner
‌
Robert A Wax
0
CPC Code
‌
A61K 47/12
0
‌
A61K 47/24
0
‌
A61K 47/26
0
‌
A61K 47/38
0
‌
A61K 9/14
0
‌
A61K 9/10
0
‌
A61K 31/451
0
‌
A61K 47/02
0

Find more entities like US Patent 11701326 Amlodipine formulations

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.